Enovis Operating Margin 2010-2025 | ENOV

Current and historical operating margin for Enovis (ENOV) over the last 10 years. The current operating profit margin for Enovis as of June 30, 2025 is 8.60%.
Enovis Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $2.19B $-0.76B -34.75%
2025-03-31 $2.15B $-0.79B -36.65%
2024-12-31 $2.11B $-0.78B -36.83%
2024-09-30 $2.00B $-0.12B -5.85%
2024-06-30 $1.91B $-0.11B -5.49%
2024-03-31 $1.82B $-0.08B -4.13%
2023-12-31 $1.71B $-0.07B -3.81%
2023-09-30 $1.66B $-0.09B -5.23%
2023-06-30 $1.63B $-0.09B -5.22%
2023-03-31 $1.59B $-0.07B -4.08%
2022-12-31 $1.56B $-0.07B -4.54%
2022-09-30 $0.99B $-0.14B -14.31%
2022-06-30 $0.96B $-0.14B -14.46%
2022-03-31 $0.92B $-0.16B -16.81%
2021-12-31 $1.43B $-0.06B -4.42%
2021-09-30 $0.47B $-0.14B -28.54%
2021-06-30 $0.92B $-0.06B -6.20%
2021-03-31 $1.18B $-0.05B -4.40%
2020-12-31 $1.12B $-0.07B -5.89%
2020-09-30 $3.13B $0.20B 6.26%
2020-06-30 $3.17B $0.20B 6.37%
2020-03-31 $3.46B $0.25B 7.20%
2019-12-31 $3.33B $0.20B 6.13%
2019-09-30 $2.67B $0.12B 4.54%
2019-06-30 $2.34B $0.09B 3.75%
2019-03-31 $2.00B $0.09B 4.56%
2018-12-31 $2.19B $0.15B 6.89%
2018-09-30 $1.48B $0.07B 4.87%
2018-06-30 $1.80B $0.11B 6.23%
2018-03-31 $2.09B $0.14B 6.57%
2017-12-31 $1.94B $0.14B 6.97%
2017-09-30 $3.01B $0.26B 8.70%
2017-06-30 $2.93B $0.25B 8.38%
2017-03-31 $3.04B $0.25B 8.18%
2016-12-31 $3.19B $0.24B 7.44%
2016-09-30 $3.13B $0.23B 7.22%
2016-06-30 $3.33B $0.21B 6.39%
2016-03-31 $3.40B $0.24B 6.97%
2015-12-31 $3.43B $0.27B 7.75%
2015-09-30 $4.11B $0.33B 7.95%
2015-06-30 $4.31B $0.40B 9.29%
2015-03-31 $4.48B $0.40B 8.91%
2014-12-31 $4.62B $0.41B 8.87%
2014-09-30 $4.59B $0.42B 9.22%
2014-06-30 $4.44B $0.41B 9.17%
2014-03-31 $4.31B $0.42B 9.81%
2013-12-31 $4.21B $0.41B 9.67%
2013-09-30 $4.06B $0.34B 8.34%
2013-06-30 $4.00B $0.29B 7.20%
2013-03-31 $3.97B $0.24B 5.94%
2012-12-31 $3.91B $0.14B 3.58%
2012-09-30 $3.06B $0.08B 2.61%
2012-06-30 $2.28B $0.03B 1.45%
2012-03-31 $1.42B $-0.01B -0.70%
2011-12-31 $0.69B $0.03B 3.60%
2011-09-30 $0.68B $0.05B 7.76%
2011-06-30 $0.65B $0.06B 8.84%
2011-03-31 $0.58B $0.05B 7.75%
2010-12-31 $0.54B $0.04B 6.46%
2010-09-30 $0.51B $0.03B 4.94%
2010-06-30 $0.50B $0.03B 5.17%
2010-03-31 $0.51B $0.03B 5.70%
2009-12-31 $0.53B $0.04B 7.62%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.740B $2.108B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.466B 59.12
Tempus AI (TEM) United States $12.696B 0.00
Doximity (DOCS) United States $11.914B 53.01
Hims & Hers Health (HIMS) United States $9.534B 78.11
IRhythm Technologies (IRTC) United States $5.093B 0.00
Hinge Health (HNGE) United States $4.374B 0.00
Inspire Medical Systems (INSP) United States $2.663B 39.16
Privia Health (PRVA) United States $2.603B 192.82
Heartflow (HTFL) $2.489B 0.00
Phreesia (PHR) United States $1.681B 0.00
10x Genomics (TXG) United States $1.669B 0.00
Omnicell (OMCL) United States $1.466B 28.24
Schrodinger (SDGR) United States $1.428B 0.00
Azenta (AZTA) United States $1.388B 60.58
Clover Health Investments (CLOV) United States $1.292B 0.00
Claritev (CTEV) United States $1.115B 0.00
Evolent Health (EVH) United States $1.057B 0.00
Fulgent Genetics (FLGT) United States $0.660B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.520B 0.00
Standard BioTools (LAB) United States $0.485B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.347B 0.00
Carlsmed (CARL) $0.333B 0.00
TruBridge (TBRG) United States $0.293B 51.40
SOPHiA GENETICS SA (SOPH) Switzerland $0.237B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.182B 0.00
MDxHealth SA (MDXH) Belgium $0.137B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.119B 0.00
CareCloud (CCLD) United States $0.115B 5.23
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.086B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00